These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4879629)

  • 21. The role of lumbar sympathectomy in the era of direct arterial surgery.
    de Medeiros A; Pinto-Ribeiro A; Parente E; de Medina AL
    Vasc Dis; 1967 Dec; 4(6):353-61. PubMed ID: 6073352
    [No Abstract]   [Full Text] [Related]  

  • 22. ADVANCES IN THE TREATMENT OF PERIPHERAL ARTERIAL DISEASE.
    MARTIN P
    Practitioner; 1963 Oct; 191():453-9. PubMed ID: 14069131
    [No Abstract]   [Full Text] [Related]  

  • 23. [THE STAGE OF OPERABILITY IN HEART DISEASES AND VASCULAR DISEASES].
    WIEBERDINK J
    Ned Tijdschr Geneeskd; 1964 Oct; 108():1933-5. PubMed ID: 14224204
    [No Abstract]   [Full Text] [Related]  

  • 24. Current status of the cholesterol hypothesis.
    Podell RN
    Am Fam Physician; 1974 Jan; 9(1):145-8. PubMed ID: 4203688
    [No Abstract]   [Full Text] [Related]  

  • 25. [A new combined therapy of intra-arterial drug injection and oral traditional Chinese medicines in treatment of thromboangiitis obliterans (author's transl)].
    Chen ZQ
    Zhonghua Wai Ke Za Zhi; 1981 Sep; 19(9):558-60. PubMed ID: 7338116
    [No Abstract]   [Full Text] [Related]  

  • 26. Ten years' dietary treatment of primary hyperlipidemia.
    Lewis LA; Brown HB; Page IH
    Geriatrics; 1970 Dec; 25(12):64-81. PubMed ID: 5483788
    [No Abstract]   [Full Text] [Related]  

  • 27. CYCLANDELATE (CYCLOSPASMOL) IN THE TREATMENT OF PERIPHERAL CIRCULATORY DISEASES.
    SMITH AL
    Angiology; 1965 Jan; 16():1-7. PubMed ID: 14258038
    [No Abstract]   [Full Text] [Related]  

  • 28. [CIRCULATORY RESEARCH ON ELEDOISIN WITH RESULTS OF THERAPY].
    GERSMEYER EF; CASTENHOLZ A; NICOLAY M
    Klin Wochenschr; 1965 Mar; 43():309-17. PubMed ID: 14284893
    [No Abstract]   [Full Text] [Related]  

  • 29. [Changes pointing to vascular disease in patients with hyperlipidemious].
    Löhr GW
    Arzneimittelforschung; 1972 Oct; 22(10):1823-5. PubMed ID: 4678573
    [No Abstract]   [Full Text] [Related]  

  • 30. [The prognosis in, and the limitations set to concervative treatment of occlusion of crural arteries (author's transl)].
    Schoop W
    Thoraxchir Vask Chir; 1976 Aug; 24(4):333-7. PubMed ID: 1086015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapy of peripheral arterial occlusive diseases. Round table conference].
    Bollinger A; Biland L; Brunner U; Kappert A; Krähenbühl B; Mahler F; Monti M; Nachbur B; Schneider E; Widmer LK
    Schweiz Med Wochenschr; 1983 Dec; 113(49):1834-6. PubMed ID: 6233698
    [No Abstract]   [Full Text] [Related]  

  • 32. [Juvenile peripheral obliterating arteriopathy. Diagnostic and etiopathogenetic problems].
    Cotti L
    Minerva Med; 1974 Jan; 65(5):249-56. PubMed ID: 4819381
    [No Abstract]   [Full Text] [Related]  

  • 33. Diagnosis and management of peripheral arterial disease.
    Peach G; Griffin M; Jones KG; Thompson MM; Hinchliffe RJ
    BMJ; 2012 Aug; 345():e5208. PubMed ID: 22893640
    [No Abstract]   [Full Text] [Related]  

  • 34. [Site of excision of the lumbar sympathetic trunk in the treatment of obliterating lesions of blood vessels of the lower limbs].
    Kolodziejczyk Z
    Folia Med Cracov; 1972; 14(2):253-62. PubMed ID: 5086170
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of functional changes in arteriosclerotic chronic obliterating peripheral arterial diseases (COPA) and Buerger's and Raynaud's diseases with pharmacological sympathicolysis, with or without indirect surgical treatment].
    Bagliani A; Borri P; Taborelli R
    Minerva Cardioangiol; 1973 Jun; 21(6):439-52. PubMed ID: 4720185
    [No Abstract]   [Full Text] [Related]  

  • 36. [Artherosclerotic ischemic coronary disease. Etiopathogenic considerations].
    Kamel D; Vaissman I; Veloso E; Rotman F; Manhães H
    Arq Bras Endocrinol Metabol; 1969 Dec; 18(3):163-84. PubMed ID: 4935190
    [No Abstract]   [Full Text] [Related]  

  • 37. The management of arteriosclerotic occlusive vascular disease with poor distal run-off.
    Toone WM
    Angiology; 1967 Jul; 18(7):409-14. PubMed ID: 6028456
    [No Abstract]   [Full Text] [Related]  

  • 38. [Medical treatment of arteriosclerosis obliterans (ASO)].
    Matsuo H
    Nihon Geka Gakkai Zasshi; 1996 Jul; 97(7):520-5. PubMed ID: 8808815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of experimental frostbite with intra-arterial sympathetic blocking drugs.
    Snider RL; Porter JM
    Surgery; 1975 Apr; 77(4):557-61. PubMed ID: 1145433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Important prognostic factors for the results of physiotherapeutic exercises in intermittent claudication (author's transl)].
    Krause D; Stang A; Zezschwitz W
    MMW Munch Med Wochenschr; 1977 Oct; 119(40):1289-94. PubMed ID: 412058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.